CN108220683A - A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method - Google Patents
A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method Download PDFInfo
- Publication number
- CN108220683A CN108220683A CN201810014492.8A CN201810014492A CN108220683A CN 108220683 A CN108220683 A CN 108220683A CN 201810014492 A CN201810014492 A CN 201810014492A CN 108220683 A CN108220683 A CN 108220683A
- Authority
- CN
- China
- Prior art keywords
- alloy
- rolling
- heat treatment
- alloys
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 28
- 229910000882 Ca alloy Inorganic materials 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 238000005275 alloying Methods 0.000 title claims description 7
- 239000000956 alloy Substances 0.000 claims abstract description 69
- 229910045601 alloy Inorganic materials 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000005096 rolling process Methods 0.000 claims abstract description 22
- 238000001125 extrusion Methods 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 11
- 229910052748 manganese Inorganic materials 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims description 32
- 238000005098 hot rolling Methods 0.000 claims description 16
- 238000005097 cold rolling Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010791 quenching Methods 0.000 claims description 8
- 239000006104 solid solution Substances 0.000 claims description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 230000000171 quenching effect Effects 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000007670 refining Methods 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 229910002804 graphite Inorganic materials 0.000 claims description 3
- 239000010439 graphite Substances 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 239000011701 zinc Substances 0.000 abstract description 31
- 229910001297 Zn alloy Inorganic materials 0.000 abstract description 21
- 239000000463 material Substances 0.000 abstract description 17
- 239000007943 implant Substances 0.000 abstract description 6
- 238000003723 Smelting Methods 0.000 abstract description 4
- 238000005034 decoration Methods 0.000 abstract description 4
- 238000013461 design Methods 0.000 abstract description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 229910001092 metal group alloy Inorganic materials 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 239000011572 manganese Substances 0.000 description 18
- 229910052725 zinc Inorganic materials 0.000 description 15
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 14
- 239000011575 calcium Substances 0.000 description 14
- 238000005266 casting Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 238000000265 homogenisation Methods 0.000 description 7
- 239000007769 metal material Substances 0.000 description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000004332 silver Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 238000009864 tensile test Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical class [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000010944 silver (metal) Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910009369 Zn Mg Inorganic materials 0.000 description 1
- 229910007570 Zn-Al Inorganic materials 0.000 description 1
- 229910007573 Zn-Mg Inorganic materials 0.000 description 1
- 229910007568 Zn—Ag Inorganic materials 0.000 description 1
- 229910007565 Zn—Cu Inorganic materials 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C18/00—Alloys based on zinc
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C1/00—Making non-ferrous alloys
- C22C1/02—Making non-ferrous alloys by melting
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22F—CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS
- C22F1/00—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working
- C22F1/16—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of other metals or alloys based thereon
- C22F1/165—Changing the physical structure of non-ferrous metals or alloys by heat treatment or by hot or cold working of other metals or alloys based thereon of zinc or cadmium or alloys based thereon
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了低合金化Zn‑Mn‑Ag或Zn‑Mn‑Ca合金及其制备方法,属于有色金属合金材料成分设计和制备技术领域。本发明提供的锌合金按质量百分比由下述成分组成:(1)0.1~5%的Mn,0.05~5%的Ag,余量为Zn;(2)0.1~5%的Mn,0.02~2%的Ca,余量为Zn。通过对真空熔炼得到的铸态合金进行轧制或挤压塑性变形,优化了合金组织,使合金具有良好的综合力学性能。所述轧制包括4条工艺路线,所述挤压包括1条工艺路线。制得的变形Zn‑Mn‑Ag和Zn‑Mn‑Ca合金可用做仪器仪表壳体、装饰品、模型和电器零件等。除此之外,上述合金也满足生物医用植入材料所需的力学性能,能够在体内降解并具有优良的细胞相容性,可作为生物医用材料植入动物体或人体。
The invention discloses a low-alloyed Zn-Mn-Ag or Zn-Mn-Ca alloy and a preparation method thereof, and belongs to the technical field of composition design and preparation of non-ferrous metal alloy materials. The zinc alloy provided by the present invention is composed of the following components by mass percentage: (1) 0.1-5% Mn, 0.05-5% Ag, and the balance is Zn; (2) 0.1-5% Mn, 0.02-2 % Ca, the balance is Zn. Through rolling or extruding plastic deformation of the as-cast alloy obtained by vacuum smelting, the alloy structure is optimized, so that the alloy has good comprehensive mechanical properties. The rolling includes 4 process routes, and the extrusion includes 1 process route. The obtained deformed Zn-Mn-Ag and Zn-Mn-Ca alloys can be used as instrument shells, decorations, models and electrical parts and the like. In addition, the above-mentioned alloys also meet the mechanical properties required for biomedical implant materials, can be degraded in vivo and have excellent cell compatibility, and can be used as biomedical materials for implantation into animals or humans.
Description
技术领域technical field
本发明涉及低合金化Zn-Mn-Ag和Zn-Mn-Ca合金的成分设计、制备方法和应用领域,属于有色金属合金材料成分设计和制备加工技术领域。The invention relates to the composition design, preparation method and application field of low-alloyed Zn-Mn-Ag and Zn-Mn-Ca alloys, and belongs to the technical field of composition design, preparation and processing of non-ferrous metal alloy materials.
背景技术Background technique
锌在我国储量丰富,成本低廉,是重要的金属材料。锌具有优良的抗腐蚀性能,被广泛的用作钢铁的镀层保护材料。其铸造性能良好,可用于砂型、金属型及压铸生产,可生产薄壁及复杂铸件。锌还由于其独特的电化学性能,被制成电源干电池而得到了广泛应用。此外,锌及其合金的轧制加工性能优良,其板带材应用在建筑、机械、运输、仪器仪表等领域。近年来,锌及其合金在可降解生物医用材料方面的潜在应用受到广泛关注。目前已报道的生物医用金属材料可分为不可降解型和可降解型。不可降解的医用金属材料,如316L不锈钢,植入人体后需要二次手术取出,会增加病人的痛苦。而降解速度过快的医用金属材料,如镁合金,则难以满足医用植入体后期所需的支撑力,容易造成血管再次堵塞。锌在人体内的降解速度低于镁却高于铁,因此最近作为可降解生物医用金属材料的重要种类获得了重视。Zinc is an important metal material with abundant reserves and low cost in my country. Zinc has excellent corrosion resistance and is widely used as a coating protection material for steel. It has good casting performance and can be used in sand mold, metal mold and die-casting production, and can produce thin-walled and complex castings. Zinc is also widely used as a power dry battery due to its unique electrochemical properties. In addition, zinc and its alloys have excellent rolling performance, and their plates and strips are used in construction, machinery, transportation, instrumentation and other fields. In recent years, the potential application of zinc and its alloys in biodegradable biomedical materials has attracted extensive attention. The reported biomedical metal materials can be divided into non-degradable and degradable types. Non-degradable medical metal materials, such as 316L stainless steel, require a second operation to remove them after being implanted in the human body, which will increase the pain of the patient. However, medical metal materials that degrade too quickly, such as magnesium alloys, are difficult to meet the supporting force required by medical implants in the later stage, and may easily cause blood vessels to block again. The degradation rate of zinc in the human body is lower than that of magnesium but higher than that of iron, so it has recently gained attention as an important category of degradable biomedical metal materials.
要拓展锌合金的用途,必须重视发展变形锌合金。现有的变形锌合金主要是Zn-Al和Zn-Cu系锌合金,应用于建筑、机械、运输等领域。文献报道的生物医用锌合金包括Zn-Mg、Zn-Cu、Zn-Li、Zn-Sr、Zn-Ag系锌合金。Al被认为可能引发早老性痴呆症,一般不作为植入用生物医用锌合金的添加元素。To expand the use of zinc alloys, we must pay attention to the development of deformed zinc alloys. The existing deformed zinc alloys are mainly Zn-Al and Zn-Cu series zinc alloys, which are used in construction, machinery, transportation and other fields. The biomedical zinc alloys reported in the literature include Zn-Mg, Zn-Cu, Zn-Li, Zn-Sr, and Zn-Ag zinc alloys. Al is considered to cause Alzheimer's disease, and it is generally not used as an additive element in biomedical zinc alloys for implants.
纯锌的力学性能较差,锰元素的加入可提高合金的力学性能和耐磨性,银元素和钙元素的加入可以细化晶粒,并且银元素在锌中的固溶度较大,可以通过固溶强化或时效强化提高锌合金强度。此外,锌、锰、银和钙都是人体所必需微量元素,成人每天需要13~15mg的锌。锌是上百种酶的辅酶,在维持细胞结构、增强免疫力和防衰老等方面起着重要的作用。锰有去脂作用,能有效改善动脉粥样硬化患者的脂质代谢,并参与造血,还可以增强免疫力。银可以起到消毒杀菌的作用,纳米银粒子作为新一代的天然抗菌剂,可以强效杀菌并促进伤口愈合。钙是牙齿、骨骼的主要成分,参与心脏搏动、肌肉收缩和血液凝固等活动,能够改善血液粘稠度,维持细胞功能,消除多余血脂和胆固醇,改善血管弹性。The mechanical properties of pure zinc are poor, and the addition of manganese can improve the mechanical properties and wear resistance of the alloy. The addition of silver and calcium can refine the grains, and the solid solubility of silver in zinc is large, which can Improve the strength of zinc alloys by solid solution strengthening or age strengthening. In addition, zinc, manganese, silver and calcium are essential trace elements for the human body. Adults need 13-15 mg of zinc per day. Zinc is the coenzyme of hundreds of enzymes and plays an important role in maintaining cell structure, enhancing immunity and anti-aging. Manganese has a fat-removing effect, can effectively improve lipid metabolism in patients with atherosclerosis, participate in hematopoiesis, and can also enhance immunity. Silver can play a role in disinfection and sterilization. Nano-silver particles, as a new generation of natural antibacterial agent, can effectively sterilize bacteria and promote wound healing. Calcium is the main component of teeth and bones. It participates in activities such as heart beat, muscle contraction and blood coagulation. It can improve blood viscosity, maintain cell function, eliminate excess blood fat and cholesterol, and improve blood vessel elasticity.
目前国内外还没有文献或专利报道本专利所发明的低合金化Zn-Mn-Ag和Zn-Mn-Ca合金的成分、制备方法和性能,并提出将这种Zn-Mn-Ag和Zn-Mn-Ca合金用于电器零件、装饰品和生物医用可降解材料。At present, there are no literature or patent reports on the composition, preparation method and performance of the low alloyed Zn-Mn-Ag and Zn-Mn-Ca alloy invented by this patent, and it is proposed to combine this Zn-Mn-Ag and Zn- Mn-Ca alloys are used in electrical parts, decorations and biomedical degradable materials.
发明内容Contents of the invention
本发明旨在提供低合金化Zn-Mn-Ag和Zn-Mn-Ca合金的成分设计、制备方法和应用领域。本发明制备的锌合金具有优良的力学性能,适用于仪器仪表壳体、装饰品、模型和电器零件等领域。并且由于Zn、Mn、Ag和Ca元素均为人体必需微量元素,上述合金还可用于生物医用植入材料。The invention aims to provide composition design, preparation method and application field of low alloyed Zn-Mn-Ag and Zn-Mn-Ca alloys. The zinc alloy prepared by the invention has excellent mechanical properties and is suitable for the fields of instrument shells, decorations, models, electrical parts and the like. And because the Zn, Mn, Ag and Ca elements are essential trace elements for the human body, the above alloys can also be used for biomedical implant materials.
本发明提供的Zn-Mn-Ag或Zn-Mn-Ca合金,包括Zn元素、Mn元素、Ag元素和Ca元素。合金元素成分范围是:(1)0.1~5%的Mn,0.05~5%的Ag,余量为Zn;(2)0.1~5%的Mn,0.02~2%的Ca,余量为Zn,上述成分以质量百分比计算。The Zn-Mn-Ag or Zn-Mn-Ca alloy provided by the present invention includes Zn element, Mn element, Ag element and Ca element. The composition range of alloying elements is: (1) 0.1-5% Mn, 0.05-5% Ag, and the balance is Zn; (2) 0.1-5% Mn, 0.02-2% Ca, and the balance is Zn, The above-mentioned ingredients are calculated by mass percentage.
如上所述的Zn-Mn-Ag或Zn-Mn-Ca合金的制备方法,具体制备步骤如下:As above-mentioned Zn-Mn-Ag or the preparation method of Zn-Mn-Ca alloy, concrete preparation steps are as follows:
1)铸造:用真空感应熔炼炉对锌合金进行熔炼,以纯Zn、纯Mn、纯Ag和纯Ca为原料,在氩气保护下加热至750℃~850℃,之后精炼保温3~15分钟,最后浇注到高纯石墨模具中空冷至室温。1) Casting: Melting the zinc alloy with a vacuum induction melting furnace, using pure Zn, pure Mn, pure Ag and pure Ca as raw materials, heating to 750 ° C ~ 850 ° C under the protection of argon, and then refining and heat preservation for 3 ~ 15 minutes, Finally, it is poured into a high-purity graphite mold and air-cooled to room temperature.
2)塑性加工:加工方法包括轧制或挤压中至少一种。2) Plastic processing: the processing method includes at least one of rolling or extrusion.
如上所述的轧制分为4种轧制工艺路线,按这4种工艺路线的任何一种都可制得成品板材,它们分别是:The above-mentioned rolling is divided into 4 kinds of rolling process routes, and the finished plate can be made according to any of these 4 kinds of process routes, which are respectively:
(1)均匀化热处理→热轧→成品;(1) Homogenization heat treatment → hot rolling → finished product;
(1)均匀化热处理→热轧→温轧→成品;(1) Homogenization heat treatment → hot rolling → warm rolling → finished product;
(3)均匀化热处理→热轧→固溶→冷轧→成品;(3) Homogenization heat treatment → hot rolling → solid solution → cold rolling → finished product;
(4)均匀化热处理→热轧→温轧→固溶→冷轧→成品。(4) Homogenization heat treatment → hot rolling → warm rolling → solid solution → cold rolling → finished product.
如上所述的挤压工艺路线为:均匀化热处理→挤压→成品。The above-mentioned extrusion process route is: homogenization heat treatment→extrusion→finished product.
上述均匀化热处理工艺为280~390℃保温5~20小时;热轧温度为200~350℃,变形量为40~95%;温轧温度为80~200℃,变形量为30~95%;固溶工艺为340~390℃保温10分钟~2小时后进行水淬;冷轧变形量为50~98%;进一步的,所述挤压温度为150~350℃,挤压比为10~90。The above-mentioned homogenization heat treatment process is 280-390°C for 5-20 hours; the hot rolling temperature is 200-350°C, and the deformation is 40-95%; the warm rolling temperature is 80-200°C, and the deformation is 30-95%; The solid solution process is 340-390 ° C for 10 minutes to 2 hours and then water quenching; the cold rolling deformation is 50-98%; further, the extrusion temperature is 150-350 ° C, and the extrusion ratio is 10-90 .
本发明的Zn-Mn-Ag或Zn-Mn-Ca合金具有良好的力学性能,易于加工成形。此外,本发明选择对人体有益的元素Mn、Ag和Ca作为添加元素来优化锌的组织和性能,使合金具有良好的力学性能和生物相容性。The Zn-Mn-Ag or Zn-Mn-Ca alloy of the invention has good mechanical properties and is easy to process and shape. In addition, the present invention selects Mn, Ag and Ca, which are beneficial to the human body, as additional elements to optimize the structure and properties of zinc, so that the alloy has good mechanical properties and biocompatibility.
本发明提供的Zn-Mn-Ag和Zn-Mn-Ca合金可用于仪器仪表壳体、装饰品、模型和电器零件等。除此之外,本发明所述锌合金还可用于生物医用植入材料,如骨钉、固定螺丝、气管支架、尿道支架等。The Zn-Mn-Ag and Zn-Mn-Ca alloys provided by the invention can be used for instrument shells, decorations, models, electrical parts and the like. In addition, the zinc alloy of the present invention can also be used in biomedical implant materials, such as bone nails, fixation screws, tracheal stents, urethral stents, and the like.
本发明具有如下优点:The present invention has the following advantages:
(1)本发明设计的Zn-Mn-Ca合金,添加元素总含量低,合金成本低,适合大范围推广使用;(1) The Zn-Mn-Ca alloy designed by the present invention has low total content of added elements, low alloy cost, and is suitable for wide-scale popularization and use;
(2)本发明设计的Zn-Mn-Ag合金,在作为生物医用材料使用时,Ag元素的添加增强了合金的抗菌性能,使合金适用于有特殊要求的生物材料;(2) The Zn-Mn-Ag alloy designed by the present invention, when used as a biomedical material, the addition of the Ag element strengthens the antibacterial properties of the alloy, making the alloy suitable for biological materials with special requirements;
(3)本发明设计的Zn-Mn-Ag和Zn-Mn-Ca合金,Ag元素和Ca元素都能够细化晶粒,尤其是Ca元素,显著细化了合金的铸态组织。此外,Ag元素在锌中的固溶度较大,使变形后的锌合金可以通过固溶强化或者时效强化进一步提升合金的强度。本发明设计的锌合金用于生物医用材料时,可同时满足医用植入体所需强度和塑性,并且合金可在体内降解,具有良好的生物相容性。(3) In the Zn-Mn-Ag and Zn-Mn-Ca alloys designed by the present invention, both the Ag element and the Ca element can refine the grains, especially the Ca element, which significantly refines the as-cast structure of the alloy. In addition, the solid solubility of Ag element in zinc is relatively large, so that the deformed zinc alloy can further improve the strength of the alloy through solid solution strengthening or aging strengthening. When the zinc alloy designed in the invention is used in biomedical materials, it can simultaneously meet the strength and plasticity required by medical implants, and the alloy can be degraded in vivo and has good biocompatibility.
附图说明Description of drawings
图1为实施例1制备的铸态锌合金的金相照片。Fig. 1 is the metallographic photograph of the as-cast zinc alloy prepared in embodiment 1.
其中图1a为铸态Zn-0.8Mn-0.4Ag合金的金相照片。Among them, Fig. 1a is a metallographic photo of as-cast Zn-0.8Mn-0.4Ag alloy.
图1b为铸态Zn-0.8Mn-0.4Ca合金的金相照片。Figure 1b is a metallographic photo of the as-cast Zn-0.8Mn-0.4Ca alloy.
图2为实施例1制备的温轧态锌合金板材的拉伸应力-应变曲线。Fig. 2 is the tensile stress-strain curve of the warm-rolled zinc alloy sheet prepared in Example 1.
其中图2a为温轧态Zn-0.8Mn-0.4Ag合金板材的拉伸应力-应变曲线。Figure 2a is the tensile stress-strain curve of the warm-rolled Zn-0.8Mn-0.4Ag alloy plate.
图2b为温轧态Zn-0.8Mn-0.4Ca合金板材的拉伸应力-应变曲线。Figure 2b is the tensile stress-strain curve of the warm-rolled Zn-0.8Mn-0.4Ca alloy sheet.
图3为实施例2制备的热轧态Zn-0.8Mn-0.8Ag合金板材的拉伸应力-应变曲线。Fig. 3 is the tensile stress-strain curve of the hot-rolled Zn-0.8Mn-0.8Ag alloy plate prepared in Example 2.
图4为实施例5制备的挤压态锌合金棒材的拉伸应力-应变曲线。Fig. 4 is the tensile stress-strain curve of the extruded zinc alloy rod prepared in Example 5.
其中图4a为挤压态Zn-0.8Mn-0.4Ag合金棒材的拉伸应力-应变曲线。Figure 4a is the tensile stress-strain curve of the extruded Zn-0.8Mn-0.4Ag alloy rod.
图4b为挤压态Zn-0.8Mn-0.4Ca合金棒材的拉伸应力-应变曲线。Figure 4b is the tensile stress-strain curve of the extruded Zn-0.8Mn-0.4Ca alloy rod.
图5为实施例6制备的挤压态Zn-0.8Mn-0.8Ag合金棒材的拉伸应力-应变曲线。Fig. 5 is the tensile stress-strain curve of the extruded Zn-0.8Mn-0.8Ag alloy rod prepared in Example 6.
具体实施方式Detailed ways
下述实施例中所使用的实验方法如无特别说明,均为常规方法。The experimental methods used in the following examples are conventional methods unless otherwise specified.
下述实施例中所用材料,如无特别说明,均可从商业途径得到。Materials used in the following examples can be obtained from commercial sources unless otherwise specified.
下述实施例中所用百分含量为质量百分含量。The percentages used in the following examples are mass percentages.
下述实施例旨在说明本发明而不是对本发明的进一步限定。The following examples are intended to illustrate the present invention without further limiting the invention.
实施例1:Example 1:
制备温轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材并测量材料的力学性能。The warm-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy sheets were prepared and the mechanical properties of the materials were measured.
工艺路线:铸造→均匀化热处理→热轧→温轧→成品。Process route: casting→homogenizing heat treatment→hot rolling→warm rolling→finished product.
熔炼使用的原材料为纯Zn(99.99%),纯Mn(99.9%)、纯Ag(99.5%)和纯Ca(99.99%),按照下面的质量百分比进行配料:(1)Mn为0.8%,Ag为0.4%,其余为Zn;(2)Mn为0.8%,Ca为0.4%,其余为Zn。将配料后的原材料装入真空感应熔炼炉的Al2O3坩埚中。之后抽取真空,待炉内气压降低至约30Pa时通入氩气,至气压达到0.035MPa时开始加热,当温度上升到780℃时停止加热进行精炼,精炼时间为5分钟,在整个熔炼过程中进行电磁搅拌。然后将合金熔体浇入直径80mm的圆柱形高纯石墨模具中,空冷至室温,制备得到Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金铸锭。图1为熔炼制备得到的铸态锌合金的金相照片,与纯锌的铸态组织相比,所述合金的铸态组织发生了显著细化,其中Zn-0.8Mn-0.4Ca合金的细化效果尤为明显。The raw material that smelting uses is pure Zn (99.99%), pure Mn (99.9%), pure Ag (99.5%) and pure Ca (99.99%), carry out batching according to following mass percentage: (1) Mn is 0.8%, Ag 0.4%, the rest is Zn; (2) Mn is 0.8%, Ca is 0.4%, and the rest is Zn. Put the batched raw materials into the Al2O3 crucible of the vacuum induction melting furnace. After that, the vacuum is drawn, and argon gas is introduced when the pressure in the furnace drops to about 30Pa, and heating is started when the pressure reaches 0.035MPa. When the temperature rises to 780°C, heating is stopped and refining is carried out. The refining time is 5 minutes. During the whole melting process Perform electromagnetic stirring. Then the alloy melt was poured into a cylindrical high-purity graphite mold with a diameter of 80mm, and air-cooled to room temperature to prepare Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy ingots. Fig. 1 is the metallographic photograph of the as-cast zinc alloy prepared by smelting, compared with the as-cast structure of pure zinc, the as-cast structure of the alloy has been significantly refined, and the fineness of the Zn-0.8Mn-0.4Ca alloy effect is particularly pronounced.
从制得的合金铸锭上切取厚度为30mm的板材,对其均匀化热处理,热处理具体工艺为380℃保温20小时,保温完成后进行水淬。A plate with a thickness of 30mm was cut from the obtained alloy ingot, and homogenized heat treatment was carried out. The specific process of heat treatment was 380°C for 20 hours, and water quenching after the heat preservation was completed.
对热处理完成后的板材先进行热轧,具体工艺为:将板材在320℃保温1小时,之后从加热炉中取出板材进行轧制,经过4道次将板材从30mm厚轧至10mm厚,变形量为66.7%,轧制过程中每2道次后进行回炉退火,退火温度依然为320℃,保温时间为10分钟,热轧结束后对板材进行水淬。然后对上述板材进行温轧,具体工艺为:将热轧板材在150℃保温30分钟后出炉进行2道次轧制将其厚度进一步减至5mm,然后进行水淬,变形量为50%。上述板材经热轧和温轧后,厚度由30mm减至5mm,总变形量为83.3%。After the heat treatment is completed, the plate is first hot-rolled. The specific process is: heat the plate at 320°C for 1 hour, and then take it out of the heating furnace for rolling. After 4 passes, the plate is rolled from 30mm thick to 10mm thick. The content is 66.7%. During the rolling process, the furnace is annealed after every 2 passes. The annealing temperature is still 320°C, and the holding time is 10 minutes. After the hot rolling, the plate is water quenched. Then carry out warm rolling to the above plate, the specific process is: heat the hot rolled plate at 150°C for 30 minutes and then take it out of the furnace for 2 passes of rolling to further reduce its thickness to 5mm, then water quenching, the deformation amount is 50%. After the above plate is hot rolled and warm rolled, the thickness is reduced from 30mm to 5mm, and the total deformation is 83.3%.
按照《GB/T 228.1-2010金属材料拉伸试验第1部分:室温试验方法》制备板材拉伸试样,采用万能材料拉伸力学试验机在室温下进行拉伸试验,拉伸应变速率为10-3/s。温轧态Zn-0.8Mn-0.4Ca和Zn-0.8Mn-0.4Ag合金的拉伸工程应力应变曲线如图2所示,可知Zn-0.8Mn-0.4Ag合金的拉伸屈服强度为118.7MPa,抗拉屈服强度为221.4MPa,延伸率为58.4%;Zn-0.8Mn-0.4Ca合金的屈服强度为153.7MPa,抗拉强度为246.3MPa,延伸率为6.2%。According to "GB/T 228.1-2010 Metal Materials Tensile Test Part 1: Room Temperature Test Method", prepare the plate tensile sample, use the universal material tensile mechanics testing machine to carry out the tensile test at room temperature, and the tensile strain rate is 10 -3 /s. The tensile engineering stress-strain curves of the warm-rolled Zn-0.8Mn-0.4Ca and Zn-0.8Mn-0.4Ag alloys are shown in Figure 2. It can be seen that the tensile yield strength of the Zn-0.8Mn-0.4Ag alloy is 118.7MPa, The tensile yield strength is 221.4MPa, the elongation is 58.4%; the yield strength of the Zn-0.8Mn-0.4Ca alloy is 153.7MPa, the tensile strength is 246.3MPa, and the elongation is 6.2%.
实施例2:Example 2:
制备热轧态Zn-0.8Mn-0.8Ag合金板材并测量材料的力学性能。The hot-rolled Zn-0.8Mn-0.8Ag alloy sheet was prepared and the mechanical properties of the material were measured.
工艺路线:铸造→均匀化热处理→热轧→成品。Process route: casting→homogenizing heat treatment→hot rolling→finished product.
该合金的成分如下:Mn为0.8%,Ag为0.8%,其余为Zn。按实施例1提供的冶炼方法制备Zn-0.8Mn-0.8Ag合金铸锭,从铸锭上切取厚度为20mm的板材。先对板材进行均匀化热处理,温度为360℃,保温6小时,然后进行水淬。之后对板材进行热轧,将板材在320℃保温1小时,然后经5个道次轧制将其厚度减至2mm,总变形量为90%。The composition of the alloy is as follows: Mn is 0.8%, Ag is 0.8%, and the rest is Zn. A Zn-0.8Mn-0.8Ag alloy ingot was prepared according to the smelting method provided in Example 1, and a plate with a thickness of 20 mm was cut from the ingot. Homogenized heat treatment is first performed on the plate at a temperature of 360°C for 6 hours, and then water quenched. Afterwards, the plate is hot-rolled, and the plate is kept at 320° C. for 1 hour, and then the thickness is reduced to 2 mm through 5 rolling passes, and the total deformation is 90%.
按实施例1提供的方法对热轧态Zn-0.8Mn-0.8Ag合金板材进行力学性能测试。热轧态Zn-0.8Mn-0.8Ag合金的拉伸工程应力应变曲线如图3所示,可知其屈服强度为144.1MPa,抗拉强度为212.4MPa,延伸率为56.3%。According to the method provided in Example 1, the mechanical properties of the hot-rolled Zn-0.8Mn-0.8Ag alloy sheet were tested. The tensile engineering stress-strain curve of the hot-rolled Zn-0.8Mn-0.8Ag alloy is shown in Figure 3. It can be seen that the yield strength is 144.1MPa, the tensile strength is 212.4MPa, and the elongation is 56.3%.
实施例3:Example 3:
制备冷轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材并测量材料的力学性能。Cold-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy sheets were prepared and the mechanical properties of the materials were measured.
工艺路线:铸造→均匀化热处理→热轧→温轧→固溶→冷轧→成品。Process route: casting→homogenizing heat treatment→hot rolling→warm rolling→solution→cold rolling→finished product.
该合金的成分如下:(1)Mn为0.8%,Ag为0.4%,其余为Zn;(2)Mn为0.8%,Ca为0.4%,其余为Zn。按实施例1提供的方法进行合金铸造→均匀化热处理→热轧→温轧,制得厚度为5mm的温轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材。先对温轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材进行固溶处理,具体工艺为在380℃保温1小时,然后水淬。然后将温轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材送入冷轧机,经过4个道次将其厚度减至1mm,冷轧变形量达90%。The composition of the alloy is as follows: (1) Mn is 0.8%, Ag is 0.4%, and the rest is Zn; (2) Mn is 0.8%, Ca is 0.4%, and the rest is Zn. Perform alloy casting→homogenizing heat treatment→hot rolling→warm rolling according to the method provided in Example 1 to obtain warm-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy sheets with a thickness of 5mm. Firstly, the warm-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy sheets are subjected to solution treatment, and the specific process is to keep the temperature at 380° C. for 1 hour, and then water quench. Then the warm-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy plates are fed into the cold rolling mill, and the thickness is reduced to 1mm after 4 passes, and the cold rolling deformation reaches 90%.
按实施例1提供的方法对冷轧态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金板材进行力学性能测试。得到冷轧态Zn-0.8Mn-0.4Ag合金板材的屈服强度为162.8MPa,抗拉强度为214.9MPa,延伸率为28.2%;冷轧态Zn-0.8Mn-0.4Ca合金板材的屈服强度为261.5MPa,抗拉强度为308.2MPa,延伸率为3.2%。According to the method provided in Example 1, the mechanical properties of the cold-rolled Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy sheets were tested. The yield strength of the cold-rolled Zn-0.8Mn-0.4Ag alloy sheet is 162.8MPa, the tensile strength is 214.9MPa, and the elongation is 28.2%; the yield strength of the cold-rolled Zn-0.8Mn-0.4Ca alloy sheet is 261.5 MPa, the tensile strength is 308.2MPa, and the elongation is 3.2%.
实施例4:Example 4:
制备冷轧态Zn-0.8Mn-0.8Ag合金板材并测量材料的力学性能。The cold-rolled Zn-0.8Mn-0.8Ag alloy sheet was prepared and the mechanical properties of the material were measured.
工艺路线:铸造→均匀化热处理→热轧→固溶→冷轧→成品。Process route: casting→homogenization heat treatment→hot rolling→solution→cold rolling→finished product.
该合金的成分如下:Mn为0.8%,Ag为0.8%,其余为Zn。按实施例2提供的方法进行合金铸造→均匀化热处理→热轧,制得厚度为2mm的热轧态Zn-0.8Mn-0.8Ag合金板材。先对热轧态Zn-0.8Mn-0.8Ag合金板材进行固溶处理,具体工艺为380℃保温1小时,然后水淬。接着将板材送入冷轧机,经过4个道次将其厚度减至0.3mm,冷轧变形量是85%。The composition of the alloy is as follows: Mn is 0.8%, Ag is 0.8%, and the rest is Zn. Perform alloy casting→homogenizing heat treatment→hot rolling according to the method provided in Example 2 to obtain a hot-rolled Zn-0.8Mn-0.8Ag alloy plate with a thickness of 2mm. Firstly, the hot-rolled Zn-0.8Mn-0.8Ag alloy plate is subjected to solution treatment, and the specific process is to keep the temperature at 380° C. for 1 hour, and then water quench. Then the plate is sent into the cold rolling mill, and its thickness is reduced to 0.3 mm through 4 passes, and the cold rolling deformation is 85%.
按实施例1提供的方法对冷轧态Zn-0.8Mn-0.8Ag合金板材进行力学性能测试。得到冷轧态Zn-0.8Mn-0.8Ag合金板材的屈服强度为129.0MPa,抗拉强度为179.0MPa,延伸率为68.5%;According to the method provided in Example 1, the mechanical properties of the cold-rolled Zn-0.8Mn-0.8Ag alloy plate were tested. The yield strength of the obtained cold-rolled Zn-0.8Mn-0.8Ag alloy plate is 129.0MPa, the tensile strength is 179.0MPa, and the elongation is 68.5%;
实施例5:Example 5:
制备挤压态Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金棒材并测量材料的力学性能。The extruded Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy rods were prepared and the mechanical properties of the materials were measured.
工艺路线:铸造→均匀化热处理→挤压→成品。Process route: casting→homogenizing heat treatment→extrusion→finished product.
上述合金的成分如下:(1)Mn为0.8%,Ag为0.4%,其余为Zn;(2)Mn为0.8%,Ca为0.4%,其余为Zn。按实施例1提供的方法制备Zn-0.8Mn-0.4Ag和Zn-0.8Mn-0.4Ca合金铸锭,从铸锭上切取直径为40mm的棒材。挤压前对棒材进行均匀化热处理,热处理工艺为在380℃保温20小时,保温完成后进行水淬。将棒材放入230℃的挤压模具中保温5分钟,然后进行立式正挤压,1道次挤压出直径为10mm的棒材,挤压比为16。挤压棒材表面质量良好,无裂纹。The composition of the above alloy is as follows: (1) Mn is 0.8%, Ag is 0.4%, and the rest is Zn; (2) Mn is 0.8%, Ca is 0.4%, and the rest is Zn. Zn-0.8Mn-0.4Ag and Zn-0.8Mn-0.4Ca alloy ingots were prepared according to the method provided in Example 1, and rods with a diameter of 40 mm were cut from the ingots. Homogenized heat treatment is carried out on the bar before extrusion. The heat treatment process is to keep warm at 380°C for 20 hours, and then water quench after the heat preservation is completed. Put the bar into an extrusion die at 230°C for 5 minutes, and then carry out vertical forward extrusion. A bar with a diameter of 10mm is extruded in one pass, and the extrusion ratio is 16. Extruded bars have good surface quality and no cracks.
按照《GB/T 228.1-2010金属材料拉伸试验第1部分:室温试验方法》制备棒材拉伸试样,采用万能材料拉伸力学试验机在室温下进行拉伸试验,拉伸应变速率为2×10-3/s。挤压态Zn-0.8Mn-0.4Ca和Zn-0.8Mn-0.4Ag合金的拉伸工程应力应变曲线如图4所示,可知,Zn-0.8Mn-0.4Ag合金的屈服强度为160.0MPa,抗拉强度为255.0MPa,延伸率为65.6%;Zn-0.8Mn-0.4Ca合金的屈服强度为254.1MPa,抗拉强度为344.0MPa,延伸率为9.1%。According to "GB/T 228.1-2010 Metal Material Tensile Test Part 1: Room Temperature Test Method", the bar tensile sample was prepared, and the tensile test was carried out at room temperature using a universal material tensile mechanics testing machine, and the tensile strain rate was 2×10 -3 /s. The tensile engineering stress-strain curves of extruded Zn-0.8Mn-0.4Ca and Zn-0.8Mn-0.4Ag alloys are shown in Figure 4. It can be seen that the yield strength of Zn-0.8Mn-0.4Ag alloy is 160.0MPa, and the The tensile strength is 255.0MPa, the elongation is 65.6%; the yield strength of the Zn-0.8Mn-0.4Ca alloy is 254.1MPa, the tensile strength is 344.0MPa, and the elongation is 9.1%.
实施例6:Embodiment 6:
制备挤压态Zn-0.8Mn-0.8Ag合金棒材并测量材料的力学性能。The extruded Zn-0.8Mn-0.8Ag alloy rods were prepared and the mechanical properties of the materials were measured.
工艺路线:铸造→均匀化热处理→挤压→成品。Process route: casting→homogenizing heat treatment→extrusion→finished product.
上述合金的成分如下:Mn为0.8%,Ag为0.8%,其余为Zn。按实施例1提供的方法制备Zn-0.8Mn-0.8Ag合金铸锭,从铸锭上切取直径为40mm的棒材。挤压前对棒材进行均匀化热处理,具体工艺为360℃保温6小时,然后水淬。将棒材放入230℃的挤压模具中保温5分钟,然后进行立式正挤压,1道次挤压出直径为10mm的棒材,挤压比为16。挤压棒材表面质量良好,无裂纹。The composition of the above alloy is as follows: Mn is 0.8%, Ag is 0.8%, and the rest is Zn. A Zn-0.8Mn-0.8Ag alloy ingot was prepared according to the method provided in Example 1, and a rod with a diameter of 40 mm was cut from the ingot. Homogenized heat treatment is carried out on the bar before extrusion, the specific process is 360 ° C for 6 hours, and then water quenching. Put the bar into an extrusion die at 230°C for 5 minutes, and then carry out vertical forward extrusion. A bar with a diameter of 10mm is extruded in one pass, and the extrusion ratio is 16. Extruded bars have good surface quality and no cracks.
按实施例5提供的方法对挤压态Zn-0.8Mn-0.8Ag合金棒材进行力学性能测试。挤压态Zn-0.8Mn-0.8Ag合金的拉伸工程应力应变曲线如图5所示,可知,Zn-0.8Mn-0.8Ag合金的屈服强度为140.4MPa,抗拉强度为252.3MPa,延伸率为68.0%。According to the method provided in Example 5, the mechanical properties of the extruded Zn-0.8Mn-0.8Ag alloy rod were tested. The tensile engineering stress-strain curve of the extruded Zn-0.8Mn-0.8Ag alloy is shown in Figure 5. It can be seen that the yield strength of the Zn-0.8Mn-0.8Ag alloy is 140.4MPa, the tensile strength is 252.3MPa, and the elongation was 68.0%.
实施例7:Embodiment 7:
对实施例1~3中制备的锌合金进行体外细胞毒性测试。In vitro cytotoxicity tests were performed on the zinc alloys prepared in Examples 1-3.
本实施例根据国标GB/T 16886.5-2003对锌合金进行体外细胞毒性测试,所采用细胞为L-929细胞。将细胞放置于由锌合金降解得到的浸提液中,在培养箱中分别进行24小时、48小时和96小时培养,培养结束后采用MTT法测量细胞吸光度并计算其相对增值率。结果表明,细胞相对增值率均在80%以上,细胞毒性为1级,因此本实施例中Zn-Mn-Ag和Zn-Mn-Ca合金的降解产物对细胞无毒,合金表现出优良的细胞相容性。In this example, an in vitro cytotoxicity test was performed on zinc alloys according to the national standard GB/T 16886.5-2003, and the cells used were L-929 cells. The cells were placed in the extract solution obtained from the degradation of the zinc alloy, and cultured in the incubator for 24 hours, 48 hours and 96 hours respectively. After the culture, the cell absorbance was measured by the MTT method and the relative proliferation rate was calculated. The results show that the relative value-added rate of the cells is above 80%, and the cytotoxicity is grade 1, so the degradation products of the Zn-Mn-Ag and Zn-Mn-Ca alloys in this example are non-toxic to the cells, and the alloys exhibit excellent cytotoxicity. compatibility.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810014492.8A CN108220683A (en) | 2018-01-08 | 2018-01-08 | A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810014492.8A CN108220683A (en) | 2018-01-08 | 2018-01-08 | A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108220683A true CN108220683A (en) | 2018-06-29 |
Family
ID=62644784
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810014492.8A Pending CN108220683A (en) | 2018-01-08 | 2018-01-08 | A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108220683A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110735066B (en) * | 2019-10-29 | 2021-04-06 | 东莞市腾美金属科技有限公司 | A kind of high-performance zinc alloy and preparation method thereof |
CN113737056A (en) * | 2021-09-09 | 2021-12-03 | 湘潭大学 | Zn-Se-based alloy material and preparation method and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107177754A (en) * | 2017-05-22 | 2017-09-19 | 北京科技大学 | A kind of high-ductility and biodegradable Zn Mn systems kirsite and preparation method thereof |
CN107460372A (en) * | 2016-06-02 | 2017-12-12 | 北京大学 | A kind of Zn Mn systems kirsite and preparation method and application |
-
2018
- 2018-01-08 CN CN201810014492.8A patent/CN108220683A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107460372A (en) * | 2016-06-02 | 2017-12-12 | 北京大学 | A kind of Zn Mn systems kirsite and preparation method and application |
CN107177754A (en) * | 2017-05-22 | 2017-09-19 | 北京科技大学 | A kind of high-ductility and biodegradable Zn Mn systems kirsite and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
沈阳有色金属加工厂: "国外锌合金的发展动态", 《机械工程材料》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110735066B (en) * | 2019-10-29 | 2021-04-06 | 东莞市腾美金属科技有限公司 | A kind of high-performance zinc alloy and preparation method thereof |
CN113737056A (en) * | 2021-09-09 | 2021-12-03 | 湘潭大学 | Zn-Se-based alloy material and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109972007B (en) | An in vivo degradable Mg-Zn-Ca-M staple material and preparation method thereof | |
CN106467942B (en) | Biodegradable medical pltine and its preparation method and application | |
CN103184379B (en) | Biodegradable Mg-Gd-Zn-Ag-Zr series magnesium alloy and preparation method thereof | |
CN109097629B (en) | Biodegradable Zn-Mo series zinc alloy and preparation method thereof | |
CN105986146B (en) | A kind of degradable medical is metal material embedded and preparation method thereof | |
US10604827B2 (en) | Biodegradable metal alloys | |
CN105349858B (en) | The bone fixation magnesium alloy implant material of degradable and preparation method | |
CN108754232B (en) | A high-strength and high-plastic biodegradable Zn-Mn-Li series zinc alloy and use thereof | |
WO2017084363A1 (en) | Medical degradable zn-cu-x alloy material and preparation method thereof | |
CN107557632A (en) | A kind of degradable biological medical Mg Zn Zr Nd alloy materials and preparation method thereof | |
CN109680195A (en) | A kind of Mg-RE system magnesium alloy and the preparation method and application thereof | |
CN104328312A (en) | Medical biodegradable zinc alloy and preparation method thereof | |
WO2018000219A1 (en) | Degradable corrosion-resistant high strength and ductility magnesium alloy for biomedical use and preparation method therefor | |
CN102433477A (en) | Biomedical Mg-Sn-Zn-Mn magnesium alloy and preparation method thereof | |
CN110317973B (en) | Biodegradable LiZn4-Zn complex phase material and preparation method thereof | |
CN111020295A (en) | A high-performance biodegradable Zn-Cu-Li-X alloy and its preparation and application methods | |
CN105401033B (en) | High strength and toughness anti-corrosion biomedical magnesium alloy | |
CN102258806B (en) | Degradable magnesium-base biomedical material for implantation in orthopaedics, and preparation method thereof | |
CN103184380B (en) | Biodegradable Mg-Gd-Zn-Sr-Zr series magnesium alloy and preparation method thereof | |
CN107198796B (en) | A kind of biomedical Zn-Mn-Cu series zinc alloy and preparation method thereof | |
AU2020102744A4 (en) | High-performance biodegradable Zn-Cu-Li-X alloy and preparation and application method thereof | |
CN108411158B (en) | A kind of biodegradable Zn-Mg-Zr alloy material, preparation method and application | |
CN108165782A (en) | A kind of medical zinc-containing alloy band and preparation method thereof | |
CN108220683A (en) | A kind of low alloying Zn-Mn-Ag or Zn-Mn-Ca alloys and preparation method | |
CN108330367B (en) | Absorbable orthopedic implant magnesium alloy and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180629 |